Literature DB >> 17412629

Aseptic cure of pulmonary paracoccidioidomycosis can be achieved after a previous subcutaneous immunization of susceptible but not resistant mice.

Celina Arruda1, Celidéia A C Vaz, Vera L G Calich.   

Abstract

The murine model of paracoccidioidomycosis, the most important South American endemic mycosis, mimics the human disease: resistance is associated with preserved cellular immunity while T-cell anergy is related with susceptibility. In the present study we asked whether a previous s.c. infection which induces strong cellular immunity would protect mice against a lethal pulmonary challenge. It was found that susceptible but not resistant mice developed immunoprotection and aseptic cure of infection. Immunoprotection led to reversal of DTH anergy, increased levels of antibodies and pulmonary IL-12, IL-2 and IL-4 indicating a balanced type 1/type 2 response. On the contrary, no marked differences in A/Sn infection and immunity were observed. Depletion experiments showed that immunoprotection required the cooperative action of CD4(+) and CD8(+) T cells in association with IFN-gamma and IL-12. Altogether, these observations demonstrated that susceptible hosts can develop sterilizing immunity and defined the main immunological requirements to control secondary paracoccidioidomycosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412629     DOI: 10.1016/j.micinf.2007.02.014

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

1.  CD28 exerts protective and detrimental effects in a pulmonary model of paracoccidioidomycosis.

Authors:  Maíra Felonato; Adriana Pina; Simone Bernardino; Flávio V Loures; Eliseu Frank de Araujo; Vera L G Calich
Journal:  Infect Immun       Date:  2010-08-16       Impact factor: 3.441

2.  Lagochilascaris minor: Susceptibility and Resistance to Experimental Infection in Mice Is Independent of H-2 Haplotype and Correlates with the Immune Response in Immunized Animals.

Authors:  Mônica Spadafora-Ferreira; Luciana Caetano Fernandes; Irmtraut Araci Hoffman Pfrimer; Cássia Regina Pichiteli; Denise Vilarinho Tambourgi; Ruy de Souza Lino-Junior; Mara Silvia Carvalhaes
Journal:  J Parasitol Res       Date:  2010-06-22

3.  Mice immunization with radioattenuated yeast cells of Paracoccidiodes brasiliensis: influence of the number of immunizations.

Authors:  Estefânia Mara do Nascimento Martins; Bernardo Sgarbi Reis; Maria Aparecida de Resende; Antero Silva Ribeiro de Andrade; Alfredo Miranda Goes
Journal:  Mycopathologia       Date:  2009-04-07       Impact factor: 2.574

Review 4.  Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy.

Authors:  Luiz R Travassos; Elaine G Rodrigues; Leo K Iwai; Carlos P Taborda
Journal:  Mycopathologia       Date:  2008 Apr-May       Impact factor: 2.574

5.  New advances in the development of a vaccine against paracoccidioidomycosis.

Authors:  Luiz R Travassos; C P Taborda
Journal:  Front Microbiol       Date:  2012-06-12       Impact factor: 5.640

6.  Indoleamine 2,3-dioxygenase controls fungal loads and immunity in Paracoccidioidomicosis but is more important to susceptible than resistant hosts.

Authors:  Eliseu F Araújo; Flávio V Loures; Silvia B Bazan; Claudia Feriotti; Adriana Pina; Alessandra S Schanoski; Tânia A Costa; Vera L G Calich
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

7.  Disease Tolerance Mediated by Phosphorylated Indoleamine-2,3 Dioxygenase Confers Resistance to a Primary Fungal Pathogen.

Authors:  Eliseu Frank de Araújo; Flávio Vieira Loures; Cláudia Feriotti; Tania Costa; Carmine Vacca; Paolo Puccetti; Luigina Romani; Vera Lúcia Garcia Calich
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.